Vitamin D3 analogues improve cafe au lait spots in patients with von Recklinghausen's disease: Experimental and clinical studies

European Journal of Dermatology

Volumn 9, Issue 3, 1999, Pages 202-206

  Nakayama, Juichiro ^a   Kiryu, Hiromaro ^b   Urabe, Kazunori ^b   Matsuo, Shinjiro ^b   Shibata, Satoko ^b   Koga, Tetsuya ^a   Furue, Masutaka ^b  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

22 Oxacalcitriol; Cafe au lait spot; Neurofibroma; Tacalcitol; Vitamin D3; Von Recklinghausen's disease

Indexed keywords

22 OXACALCITRIOL; BROXURIDINE; COLECALCIFEROL DERIVATIVE; MELANIN; TACALCITOL; 1 ALPHA,24 DIHYDROXYVITAMIN D3; 1 ALPHA,24-DIHYDROXYVITAMIN D3; CALCITRIOL; COLECALCIFEROL; DERMATOLOGICAL AGENT; DIHYDROXYCOLECALCIFEROL; DRUG DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CAFE AU LAIT SPOT; CASE REPORT; CHILD; CONTROLLED STUDY; DRUG EFFICACY; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; MELANOCYTE; NEUROFIBROMATOSIS; NONHUMAN; NUDE MOUSE; OINTMENT; SKIN BIOPSY; SKIN GRAFT; TOPICAL DRUG ADMINISTRATION; ANIMAL; CLINICAL TRIAL; METABOLISM; MIDDLE AGED; MOUSE;

ADMINISTRATION, TOPICAL; ADULT; ANIMALS; CAFE-AU-LAIT SPOTS; CALCITRIOL; CHILD; CHOLECALCIFEROL; DERMATOLOGIC AGENTS; DIHYDROXYCHOLECALCIFEROLS; FEMALE; HUMANS; MALE; MELANINS; MICE; MICE, NUDE; MIDDLE AGED; NEUROFIBROMATOSIS 1; OINTMENTS;

EID: 0033112944     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. 3 analogues on the growth of cells isolated from neurofibromas in patients with von Recklinghausen neurofibromatosis I. Eur J Dermatol 1997; 7: 169-72.
2. 3 analogue 22-oxacalcitriol, on the growth of neurofibroma cells xenografted into nude mouse skin in vivo. Eur J Dermatol 1997; 7: 475-9.
3. 3. Urabe A, Nakayama J, Terao H, Hori Y. Increased binding sites of dansylated cyclosporin A in psoriatic epidermis grafted onto nuae mice during cyclosporin A treatment. Eur J Dermatol 1991; 1: 61-4.
4. 4. Nakayama J, Urabe A, Nakagawa H, Toyofuku K, Hori Y. Responses of neurofibroma cells transplanted into nude mice skins to the injected growth factors: proliferation assayed by BrdU and immunofluorescent staining pattern of vimentin. Jpn J Dermatol 1994; 104: 1121-6 (in Japanese).
5. 3 is a novel, safe, effective therapy for the treatment of psoriasis: a three year experience and histologie analysis. J Invest Dermatol 1989; 92: 446.
6. 3 for the treatment of psoriasis. Review of the literature. Eur J Dermatol 1993; 3: 255-61.
7. 3 and calcium on growth and differentiation and on c-fos and p53 gene expression in normal human keratinocytes. J Invest Dermatol 1994; 103: 323-9.
8. 3 on inflammatory responses in psoriasis. Eur J Dermatol 1998; 1: 16-20.
9. 9. Biwer E, Uerlich M, Wimheuer R, Kreysel HW. Dermatological, epidermatological, morphological and biochemical aspects of von Recklinghausen's disease. In: Ishibashi Y and Hori Y, editors. Tuberous sclerosis and neurofibromatosis: epidemiology, pathophysiology, biology and management. Excerpta Medica, Elsevier Science Publishers B.V., 1990: 135-44.
10. 3 analogue. J Dermatol Sci 1997; 15: 113 (abstract).
11. 11. Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 1998; 197: 167-70.
12. 12. Schallreuter KU, Pittelkow MR, Swanson NN. Defective calcium transport in vitiliginous melanocytes. Arch Dermatol Res 1996; 288: 11-3.
13. 3 on epidermal melanocytes. J Cell Physiol 1988; 136: 273-80.